Cellosaurus NAT-30 (CVCL_U821)
| Cell line name | NAT-30 | ||||
|---|---|---|---|---|---|
| Synonyms | NAT 30 | ||||
| Accession | CVCL_U821 | ||||
| Resource Identification Initiative | To cite this cell line use: NAT-30 (RRID:CVCL_U821) | ||||
| Comments | Group: Hybridoma fusion partner cell line. Population: African; Kenyan. Virology: Contains 2 integrated copies of EBV genome on chromosome 1. Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG). Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV). Cell type: B-cell; CL=CL_0000236. | ||||
| Sequence variations |
| ||||
| Disease | EBV-related Burkitt lymphoma (NCIt: C27694) Burkitt lymphoma (ORDO: Orphanet_543) | ||||
| Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) | ||||
| Hierarchy | Parent: CVCL_0067 (Namalwa) Children:
| ||||
| Sex of cell | Female | ||||
| Age at sampling | Children | ||||
| Category | Cancer cell line | ||||
| Publications | PubMed=3902783; DOI=10.1007/BF02620891 PubMed=1368811; DOI=10.1007/BF02525493 | ||||
| Cross-references | |||||
| Cell line databases/resources | cancercelllines; CVCL_U821 | ||||
| Encyclopedic resources | Wikidata; Q54907486 | ||||
| Entry history | |||||
| Entry creation | 16-Apr-2014 | ||||
| Last entry update | 19-Dec-2024 | ||||
| Version number | 19 | ||||